The invention provides a novel JAK (Janus kinase) selective inhibitor and a preparation method thereof and use thereof, in particular, the invention discloses a compound having the structure represented by the formula I or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, hydrate or solvate thereof which can be used as the JAK kinase inhibitor.